Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00461812 · ClinicalTrials.gov registry record · Phase 4
A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma
A Phase 4 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 33
- Enrollment target
NCT00461812: Clinical Trial Phase 4 study, sponsored by Johns Hopkins University.
NCT00461812 is a Phase 4 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00461812, a Phase 4 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 33 participants
- Enrollment target
Study Summary
The research hypothesis for the proposed study asks the question, can Asmanex® demonstrate comparable anti-inflammatory therapeutic efficacy to the combination product, Advair® in control of mild persistent asthma? The purpose is to demonstrate that the anti-inflammatory protection afforded by monotherapy with an inhaled steroid (Asmanex®) is comparable to combination therapy with Advair® 100/50, when measured by this standard methodology (methacholine bronchoprovocation) in subjects with mild persistent asthma.
Interventions
- DRUG Mometasone
- DRUG Advair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2007-04 |
| Est. Completion | 2010-01-19 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00461812
The ClinicalTrials.gov registry entry for NCT00461812 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mometasone is the first listed.
NCT00461812 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00461812 about?
NCT00461812 is a clinical study titled "A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma". The research hypothesis for the proposed study asks the question, can Asmanex® demonstrate comparable anti-inflammatory therapeutic efficacy to the combination product, Advair® in control of mild persistent asthma? The purpose is to demonstrate that the anti-inflammatory protection afforded by mono...
What is the current status of trial NCT00461812?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 33 participants. The study started on 2007-04. Estimated completion is 2010-01-19.
What interventions are being tested in trial NCT00461812?
The interventions under investigation include: Mometasone (DRUG), Advair (DRUG).
Who is sponsoring clinical trial NCT00461812?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.